Mostrando 10 resultados de: 41
Publisher
Journal of Neuroscience Research(4)
Neurochemistry International(3)
Pharmacological Research(3)
Free Radical Research(2)
Hippocampus(2)
Área temáticas
Enfermedades(31)
Fisiología humana(23)
Farmacología y terapéutica(17)
Fisiología y materias afines(10)
Bioquímica(9)
Área de conocimiento
Neurología(24)
Neuropsicología(14)
Biología celular(12)
Farmacología(8)
Biología molecular(4)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(41)
ODS 10: Reducción de las desigualdades(29)
ODS 9: Industria, innovación e infraestructura(18)
ODS 12: Producción y consumo responsables(11)
ODS 2: Hambre cero(7)
Origen
scopus(41)
Erratum: Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment (Journal of Neurochemistry (2010) 114 (1315-1322))
OtherAbstract:Palabras claves:Autores:Antoni Camins, Auladell C., De Lemos M.L., Ferrer I., Folch J., Junyent F., Pallás M., Romero R., Verdaguer E.Fuentes:scopusGSK3β inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neurons
ArticleAbstract: In the present study, we evaluated the effects of roscovitine (Rosco) and flavopiridol (Flavo), bothPalabras claves:apoptosis, Cerebellar granular cells, flavopiridol, GSK3β, RoscovitineAutores:Antoni Camins, Auladell C., de la Torre A.V., Folch J., Junyent F., Pallás M., Pelegrí Gabalda C., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopusGene expression profile in JNK3 null mice: A novel specific activation of the PI3K/AKT pathway
ArticleAbstract: JNK3 is mainly expressed in the CNS and it plays a crucial role in neuronal death in several neurodePalabras claves:Akt, Gene profiling, JNK, Neurodegeneration, neuroprotection, PI3KAutores:Antoni Camins, Auladell C., De Lemos M.L., Ferrer I., Folch J., Junyent F., Ortuo-Sahagún D., Pallás M., Romero R., Verdaguer E., Zárate C.B.Fuentes:scopusDecrease of calbindin-d28k, calretinin, and parvalbumin by taurine treatment does not induce a major susceptibility to kainic acid
ArticleAbstract: Taurine, 2-aminoethanesulfonic acid, is present at high concentrations in many invertebrate and vertPalabras claves:calcium, Epilepsy, neuronal death, neuroprotectionAutores:Antoni Camins, Auladell C., De Lemos M.L., Junyent F., Pallás M., Porquet D., Romero R., Utrera J.Fuentes:scopusCell cycle control by ataxia telangiectasia mutated protein through regulating retinoblastoma protein phosphorylation
Book PartAbstract: The ability of cells to maintain their genomic integrity is essential to the prevention of cancer dePalabras claves:Autores:Antoni Camins, Auladell C., Folch J., Junyent F., Pallás M., Pizarro J.G., Verdaguer E., Zárate C.B.Fuentes:scopusContent and traffic of taurine in hippocampal reactive astrocytes
ArticleAbstract: Taurine is one of the most abundant free amino acids in the mammalian central nervous system, wherePalabras claves:Astrogliosis, Epilepsy, Kainic acid, neuroprotection, Taurine transporterAutores:Aguado F., Antoni Camins, Auladell C., De Lemos M.L., Junyent F., Paco S., Pallás M., Romero R., Utrera J.Fuentes:scopusEffects of MPP<sup>+</sup> on the molecular pathways involved in cell cycle control in B65 neuroblastoma cells
ArticleAbstract: The toxicity caused by cell exposure to 1-methyl-4-phenylpyridinium ion (MPP+) is a useful model inPalabras claves:apoptosis, Caspases, cell cycle, γH2AXAutores:Antoni Camins, Folch J., Jordan J., Junyent F., Pallás M., Pizarro J.G., Verdaguer E., Zárate C.B.Fuentes:scopus3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility
ArticleAbstract: Kainic acid (KA) causes seizures and neuronal loss in the hippocampus. The present study investigatePalabras claves:Calbindin, Calretinin, Kainic acid, MDMA, Parvalbumin, seizuresAutores:Abad S., Antoni Camins, Auladell C., Camarasa J., Escubedo E., Junyent F., Pallás M., Pubill D.Fuentes:scopusAn overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders
ReviewAbstract: Importance of the field: The increase in life expectancy in developed countries has given rise to sePalabras claves:Alzheimer's disease, apoptosis, Neuroprotective drugs, Parkinson's DiseaseAutores:Antoni Camins, Folch J., Junyent F., Pallás M., Sureda F.X., Verdaguer E., Zárate C.B.Fuentes:scopusAntiapoptotic drugs: A therapautic strategy for the prevention of neurodegenerative diseases
ReviewAbstract: The purpose of this review is to discuss potential pathways involved in the pathogenesis of neurodegPalabras claves:Alzheimer's disease, apoptosis, Cyclin-dependent kinases, Glutamate receptors, Neuronal cell death, Neuroprotective drugs. apoptosis, Parkinson's DiseaseAutores:Antoni Camins, Auladell C., Canudas A.M., Folch J., Junyent F., Pallás M., Pelegrí Gabalda C., Sureda F.X., Verdaguer E., Vilaplana J., Zárate C.B.Fuentes:scopus